,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1406440,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4776,NFATC4,https://ctdbase.org/detail.go?type=gene&acc=4776,,,4776.0,NFATC4,9606,Homo sapiens (human),1-methyl-4-phenylpyridinium results in decreased expression of NFATC4 mRNA,,,PMID:25234470,https://www.ncbi.nlm.nih.gov/pubmed/25234470,25234470,,
1,1406441,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Tideglusib promotes the reaction [1-methyl-4-phenylpyridinium results in increased expression of NFE2L2 mrna]|nfe2l2 protein promotes the reaction [pioglitazone inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of NQO1 mrna]]|pioglitazone inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of NFE2L2 mrna]|pioglitazone promotes the reaction [1-methyl-4-phenylpyridinium results in increased expression of NFE2L2 mrna]|nfe2l2 protein promotes the reaction [pioglitazone inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of NQO1 protein]]|1-methyl-4-phenylpyridinium results in increased expression of NFE2L2 mrna|nfe2l2 protein promotes the reaction [tideglusib inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of NQO1 protein]]|tideglusib inhibits the reaction [1-methyl-4-phenylpyridinium results in increased expression of NFE2L2 mrna]|nfe2l2 protein promotes the reaction [tideglusib inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of HMOX1 mrna]]|nfe2l2 protein promotes the reaction [tideglusib inhibits the reaction [1-methyl-4-phenylpyridinium results in decreased expression of NQO1 mrna]],,,PMID:30965670,https://www.ncbi.nlm.nih.gov/pubmed/30965670,30965670,,
2,1406442,39484,Comparative Toxicogenomics Database (CTD),Cyperquat,D015655,1-Methyl-4-phenylpyridinium,https://ctdbase.org/detail.go?type=chem&acc=D015655,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,10090,Mus musculus (house mouse),NFE2L2 protein affects the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC protein]|fyn protein affects the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of NFE2L2 protein]|lithium chloride inhibits the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of NFE2L2 protein]|[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased activity of and affects the localization of NFE2L2 protein|[1-methyl-4-phenylpyridinium co-treated with puerarin] affects the localization of NFE2L2 protein|nfe2l2 protein affects the reaction [[1-methyl-4-phenylpyridinium co-treated with puerarin] results in increased expression of GCLC mrna],,,PMID:32763437,https://www.ncbi.nlm.nih.gov/pubmed/32763437,32763437,,
3,1406628,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,1995,ELAVL3,https://ctdbase.org/detail.go?type=gene&acc=1995,,,1995.0,ELAVL3,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELAVL3 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
4,1406629,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,102725541,ELDR,https://ctdbase.org/detail.go?type=gene&acc=102725541,,,102725541.0,ELDR,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELDR mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
5,1406630,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,1999,ELF3,https://ctdbase.org/detail.go?type=gene&acc=1999,,,1999.0,ELF3,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELF3 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
6,1406631,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,392617,ELFN1,https://ctdbase.org/detail.go?type=gene&acc=392617,,,392617.0,ELFN1,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELFN1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
7,1406632,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,114794,ELFN2,https://ctdbase.org/detail.go?type=gene&acc=114794,,,114794.0,ELFN2,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELFN2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
8,1406633,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,9844,ELMO1,https://ctdbase.org/detail.go?type=gene&acc=9844,,,9844.0,ELMO1,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ELMO1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
9,1406634,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,63916,ELMO2,https://ctdbase.org/detail.go?type=gene&acc=63916,,,63916.0,ELMO2,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELMO2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
10,1406747,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,84337,ELOF1,https://ctdbase.org/detail.go?type=gene&acc=84337,,,84337.0,ELOF1,10090,Mus musculus (house mouse),Triptonide results in increased expression of ELOF1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
11,1406748,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,79071,ELOVL6,https://ctdbase.org/detail.go?type=gene&acc=79071,,,79071.0,ELOVL6,10090,Mus musculus (house mouse),Triptonide affects the expression of ELOVL6 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
12,1406749,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,23587,ELP5,https://ctdbase.org/detail.go?type=gene&acc=23587,,,23587.0,ELP5,10090,Mus musculus (house mouse),Triptonide affects the expression of ELP5 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
13,1406750,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,83460,EMC6,https://ctdbase.org/detail.go?type=gene&acc=83460,,,83460.0,EMC6,10090,Mus musculus (house mouse),Triptonide results in increased expression of EMC6 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
14,1406751,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2010,EMD,https://ctdbase.org/detail.go?type=gene&acc=2010,,,2010.0,EMD,10090,Mus musculus (house mouse),Triptonide results in increased expression of EMD mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
15,1406752,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,146956,EME1,https://ctdbase.org/detail.go?type=gene&acc=146956,,,146956.0,EME1,10090,Mus musculus (house mouse),Triptonide results in increased expression of EME1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
16,1406753,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,197342,EME2,https://ctdbase.org/detail.go?type=gene&acc=197342,,,197342.0,EME2,10090,Mus musculus (house mouse),Triptonide results in increased expression of EME2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
17,1406865,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,11117,EMILIN1,https://ctdbase.org/detail.go?type=gene&acc=11117,,,11117.0,EMILIN1,10090,Mus musculus (house mouse),Triptonide results in increased expression of EMILIN1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
18,1406866,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2009,EML1,https://ctdbase.org/detail.go?type=gene&acc=2009,,,2009.0,EML1,10090,Mus musculus (house mouse),Triptonide results in decreased expression of EML1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
19,1406867,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,24139,EML2,https://ctdbase.org/detail.go?type=gene&acc=24139,,,24139.0,EML2,10090,Mus musculus (house mouse),Triptonide results in increased expression of EML2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
20,1406868,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,27436,EML4,https://ctdbase.org/detail.go?type=gene&acc=27436,,,27436.0,EML4,10090,Mus musculus (house mouse),Triptonide affects the expression of EML4 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
21,1406869,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,56946,EMSY,https://ctdbase.org/detail.go?type=gene&acc=56946,,,56946.0,EMSY,10090,Mus musculus (house mouse),Triptonide results in decreased expression of EMSY mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
22,1406870,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2020,EN2,https://ctdbase.org/detail.go?type=gene&acc=2020,,,2020.0,EN2,10090,Mus musculus (house mouse),Triptonide results in increased expression of EN2 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
23,1406871,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,55740,ENAH,https://ctdbase.org/detail.go?type=gene&acc=55740,,,55740.0,ENAH,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ENAH mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
24,1406872,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2021,ENDOG,https://ctdbase.org/detail.go?type=gene&acc=2021,,,2021.0,ENDOG,10090,Mus musculus (house mouse),Triptonide results in increased expression of ENDOG mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
25,1406873,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,284131,ENDOV,https://ctdbase.org/detail.go?type=gene&acc=284131,,,284131.0,ENDOV,10090,Mus musculus (house mouse),Triptonide results in increased expression of ENDOV mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
26,1406874,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,2023,ENO1,https://ctdbase.org/detail.go?type=gene&acc=2023,,,2023.0,ENO1,10090,Mus musculus (house mouse),Triptonide results in decreased expression of ENO1 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
27,1407133,65411,Comparative Toxicogenomics Database (CTD),Triptonide,C084079,triptonide,https://ctdbase.org/detail.go?type=chem&acc=C084079,284656,EPHA10,https://ctdbase.org/detail.go?type=gene&acc=284656,,,284656.0,EPHA10,10090,Mus musculus (house mouse),Triptonide results in increased expression of EPHA10 mRNA,,,PMID:33045310,https://www.ncbi.nlm.nih.gov/pubmed/33045310,33045310,,
28,1406443,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,3283,HSD3B1,https://ctdbase.org/detail.go?type=gene&acc=3283,,,3283.0,HSD3B1,10116,Rattus norvegicus (Norway rat),Nonylphenol results in decreased expression of HSD3B1 mRNA,,,PMID:17229994,https://www.ncbi.nlm.nih.gov/pubmed/17229994,17229994,,
29,1406444,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,3772576,HSP22,https://ctdbase.org/detail.go?type=gene&acc=3772576,,,3772576.0,Hsp22,7227,Drosophila melanogaster (fruit fly),Nonylphenol results in decreased expression of HSP22 mRNA,,,PMID:36603486,https://www.ncbi.nlm.nih.gov/pubmed/36603486,36603486,,
30,1406445,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,403612,HSP70,https://ctdbase.org/detail.go?type=gene&acc=403612,,,403612.0,HSP70,7153,Chironomus tentans,Nonylphenol results in increased expression of HSP70 mRNA,,,PMID:16624371,https://www.ncbi.nlm.nih.gov/pubmed/16624371,16624371,,
31,1406446,67296,Comparative Toxicogenomics Database (CTD),2-Nonylphenol,C025256,nonylphenol,https://ctdbase.org/detail.go?type=chem&acc=C025256,403612,HSP70,https://ctdbase.org/detail.go?type=gene&acc=403612,,,403612.0,HSP70,85417,Gobius niger (black goby),Nonylphenol results in increased expression of HSP70 mRNA,,,PMID:19456386,https://www.ncbi.nlm.nih.gov/pubmed/19456386,19456386,,
32,1406538,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2147,F2,https://ctdbase.org/detail.go?type=gene&acc=2147,,,2147.0,F2,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of F2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
33,1406539,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2149,F2R,https://ctdbase.org/detail.go?type=gene&acc=2149,,,2149.0,F2R,9606,Homo sapiens (human),Fulvestrant results in increased expression of F2R mRNA,,,PMID:12154049,https://www.ncbi.nlm.nih.gov/pubmed/12154049,12154049,,
34,1406540,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2150,F2RL1,https://ctdbase.org/detail.go?type=gene&acc=2150,,,2150.0,F2RL1,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of F2RL1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
35,1406541,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,148753,FAM163A,https://ctdbase.org/detail.go?type=gene&acc=148753,,,148753.0,FAM163A,9606,Homo sapiens (human),Fulvestrant results in increased methylation of FAM163A gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
36,1406542,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2157,F8,https://ctdbase.org/detail.go?type=gene&acc=2157,,,2157.0,F8,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of F8 gene|[bisphenol F co-treated with fulvestrant] results in decreased methylation of F8 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
37,1406543,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2166,FAAH,https://ctdbase.org/detail.go?type=gene&acc=2166,,,2166.0,FAAH,45623,Pelophylax lessonae (pool frog),Fulvestrant inhibits the reaction [anandamide results in increased expression of FAAH protein]|fulvestrant inhibits the reaction [estradiol results in increased expression of FAAH protein],,,PMID:26586207,https://www.ncbi.nlm.nih.gov/pubmed/26586207,26586207,,
38,1406544,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,158584,FAAH2,https://ctdbase.org/detail.go?type=gene&acc=158584,,,158584.0,FAAH2,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FAAH2 gene|fulvestrant results in decreased methylation of FAAH2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
39,1406635,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,283,ANG,https://ctdbase.org/detail.go?type=gene&acc=283,,,283.0,ANG,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ANG gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
40,1406636,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23452,ANGPTL2,https://ctdbase.org/detail.go?type=gene&acc=23452,,,23452.0,ANGPTL2,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ANGPTL2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
41,1406754,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51281,ANKMY1,https://ctdbase.org/detail.go?type=gene&acc=51281,,,51281.0,ANKMY1,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ANKMY1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
42,1406755,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55608,ANKRD10,https://ctdbase.org/detail.go?type=gene&acc=55608,,,55608.0,ANKRD10,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ANKRD10 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
43,1406756,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,29123,ANKRD11,https://ctdbase.org/detail.go?type=gene&acc=29123,,,29123.0,ANKRD11,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ANKRD11 gene|[bis(4-hydroxyphenyl)sulfone co-treated with fulvestrant] results in increased methylation of ANKRD11 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
44,1407134,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,325,APCS,https://ctdbase.org/detail.go?type=gene&acc=325,,,325.0,APCS,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of APCS gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
45,1407135,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,200558,APLF,https://ctdbase.org/detail.go?type=gene&acc=200558,,,200558.0,APLF,9606,Homo sapiens (human),Cadmium inhibits the reaction [fulvestrant results in increased expression of APLF mrna]|fulvestrant results in increased expression of APLF mrna|arsenite inhibits the reaction [fulvestrant results in increased expression of APLF mrna],,,PMID:31646340,https://www.ncbi.nlm.nih.gov/pubmed/31646340,31646340,,
46,1407136,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,335,APOA1,https://ctdbase.org/detail.go?type=gene&acc=335,,,335.0,APOA1,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [quercetin results in increased secretion of APOA1 protein],,,PMID:24963805,https://www.ncbi.nlm.nih.gov/pubmed/24963805,24963805,,
47,1407137,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,100533990,APOC4-APOC2,https://ctdbase.org/detail.go?type=gene&acc=100533990,,,100533990.0,APOC4-APOC2,9606,Homo sapiens (human),Fulvestrant results in increased methylation of APOC4-APOC2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
48,1407138,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,347,APOD,https://ctdbase.org/detail.go?type=gene&acc=347,,,347.0,APOD,9606,Homo sapiens (human),Fulvestrant inhibits the reaction [estradiol results in decreased expression of APOD protein]|[estradiol co-treated with fulvestrant] results in decreased expression of APOD protein|fulvestrant results in decreased expression of APOD protein,,,PMID:27163517,https://www.ncbi.nlm.nih.gov/pubmed/27163517,27163517,,
49,1407139,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,347,APOD,https://ctdbase.org/detail.go?type=gene&acc=347,,,347.0,APOD,9606,Homo sapiens (human),Fulvestrant results in increased expression of APOD mRNA,,,PMID:16514628,https://www.ncbi.nlm.nih.gov/pubmed/16514628,16514628,,
50,1407140,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,80833,APOL3,https://ctdbase.org/detail.go?type=gene&acc=80833,,,80833.0,APOL3,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of APOL3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
51,1407141,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55937,APOM,https://ctdbase.org/detail.go?type=gene&acc=55937,,,55937.0,APOM,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of APOM gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
52,1407275,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23219,FBXO28,https://ctdbase.org/detail.go?type=gene&acc=23219,,,23219.0,FBXO28,9606,Homo sapiens (human),Fulvestrant results in decreased methylation of FBXO28 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO28 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
53,1407276,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,26273,FBXO3,https://ctdbase.org/detail.go?type=gene&acc=26273,,,26273.0,FBXO3,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
54,1407277,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,84085,FBXO30,https://ctdbase.org/detail.go?type=gene&acc=84085,,,84085.0,FBXO30,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO30 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
55,1407278,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,114907,FBXO32,https://ctdbase.org/detail.go?type=gene&acc=114907,,,114907.0,FBXO32,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FBXO32 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
56,1407279,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,51725,FBXO40,https://ctdbase.org/detail.go?type=gene&acc=51725,,,51725.0,FBXO40,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FBXO40 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
57,1407280,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,26271,FBXO5,https://ctdbase.org/detail.go?type=gene&acc=26271,,,26271.0,FBXO5,9606,Homo sapiens (human),Fulvestrant results in decreased expression of FBXO5 mrna|[fulvestrant co-treated with sirolimus] results in decreased expression of FBXO5 mRNA,,,PMID:19016759,https://www.ncbi.nlm.nih.gov/pubmed/19016759,19016759,,
58,1407281,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,25793,FBXO7,https://ctdbase.org/detail.go?type=gene&acc=25793,,,25793.0,FBXO7,9606,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of FBXO7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
59,1407414,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,55079,FEZF2,https://ctdbase.org/detail.go?type=gene&acc=55079,,,55079.0,FEZF2,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FEZF2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
60,1407415,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2257,FGF12,https://ctdbase.org/detail.go?type=gene&acc=2257,,,2257.0,FGF12,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of FGF12 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
61,1407416,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,2258,FGF13,https://ctdbase.org/detail.go?type=gene&acc=2258,,,2258.0,FGF13,9606,Homo sapiens (human),Fulvestrant results in increased methylation of FGF13 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of FGF13 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
62,1407535,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,158763,ARHGAP36,https://ctdbase.org/detail.go?type=gene&acc=158763,,,158763.0,ARHGAP36,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGAP36 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
63,1407536,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,143872,ARHGAP42,https://ctdbase.org/detail.go?type=gene&acc=143872,,,143872.0,ARHGAP42,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGAP42 gene|fulvestrant results in increased methylation of ARHGAP42 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
64,1407537,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,23526,ARHGAP45,https://ctdbase.org/detail.go?type=gene&acc=23526,,,23526.0,ARHGAP45,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ARHGAP45 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
65,1407538,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9138,ARHGEF1,https://ctdbase.org/detail.go?type=gene&acc=9138,,,9138.0,ARHGEF1,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ARHGEF1 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
66,1407651,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,9828,ARHGEF17,https://ctdbase.org/detail.go?type=gene&acc=9828,,,9828.0,ARHGEF17,9606,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of ARHGEF17 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
67,1407652,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,26084,ARHGEF26,https://ctdbase.org/detail.go?type=gene&acc=26084,,,26084.0,ARHGEF26,9606,Homo sapiens (human),Fulvestrant results in increased methylation of ARHGEF26 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
68,1407653,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,50650,ARHGEF3,https://ctdbase.org/detail.go?type=gene&acc=50650,,,50650.0,ARHGEF3,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGEF3 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
69,1407654,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,54848,ARHGEF38,https://ctdbase.org/detail.go?type=gene&acc=54848,,,54848.0,ARHGEF38,9606,Homo sapiens (human),Fulvestrant results in increased methylation of ARHGEF38 gene|[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGEF38 gene|[bisphenol F co-treated with fulvestrant] results in increased methylation of ARHGEF38 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
70,1407655,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,84904,ARHGEF39,https://ctdbase.org/detail.go?type=gene&acc=84904,,,84904.0,ARHGEF39,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in decreased methylation of ARHGEF39 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
71,1407656,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,50649,ARHGEF4,https://ctdbase.org/detail.go?type=gene&acc=50649,,,50649.0,ARHGEF4,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGEF4 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
72,1407657,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,8874,ARHGEF7,https://ctdbase.org/detail.go?type=gene&acc=8874,,,8874.0,ARHGEF7,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of ARHGEF7 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
73,1407786,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,100528031,FKBP1A-SDCBP2,https://ctdbase.org/detail.go?type=gene&acc=100528031,,,100528031.0,FKBP1A-SDCBP2,9606,Homo sapiens (human),[bisphenol A co-treated with fulvestrant] results in increased methylation of FKBP1A-SDCBP2 gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
74,1407787,104741,Comparative Toxicogenomics Database (CTD),Fulvestrant,D000077267,Fulvestrant,https://ctdbase.org/detail.go?type=chem&acc=D000077267,64778,FNDC3B,https://ctdbase.org/detail.go?type=gene&acc=64778,,,64778.0,FNDC3B,9606,Homo sapiens (human),[bisphenol F co-treated with fulvestrant] results in increased methylation of FNDC3B gene,,,PMID:31601247,https://www.ncbi.nlm.nih.gov/pubmed/31601247,31601247,,
75,1407272,168140,Comparative Toxicogenomics Database (CTD),Dimethyl thiophosphate,C040340,"O,O-dimethyl phosphorothionate",https://ctdbase.org/detail.go?type=chem&acc=C040340,58,ACTA1,https://ctdbase.org/detail.go?type=gene&acc=58,,,58.0,ACTA1,9986,Oryctolagus cuniculus (rabbit),"O,O-dimethyl phosphorothionate results in decreased activity of ACTA1 protein",,,PMID:37270087,https://www.ncbi.nlm.nih.gov/pubmed/37270087,37270087,,
76,1407273,168140,Comparative Toxicogenomics Database (CTD),Dimethyl thiophosphate,C040340,"O,O-dimethyl phosphorothionate",https://ctdbase.org/detail.go?type=chem&acc=C040340,998,CDC42,https://ctdbase.org/detail.go?type=gene&acc=998,,,998.0,CDC42,10090,Mus musculus (house mouse),"O,O-dimethyl phosphorothionate results in increased activity of CDC42 protein",,,PMID:37270087,https://www.ncbi.nlm.nih.gov/pubmed/37270087,37270087,,
77,1407274,168140,Comparative Toxicogenomics Database (CTD),Dimethyl thiophosphate,C040340,"O,O-dimethyl phosphorothionate",https://ctdbase.org/detail.go?type=chem&acc=C040340,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10090,Mus musculus (house mouse),"O,O-dimethyl phosphorothionate results in increased activity of RAC1 protein",,,PMID:37270087,https://www.ncbi.nlm.nih.gov/pubmed/37270087,37270087,,
78,1407539,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005267,DNA-directed RNA polymerase II subunit RPB11-a,http://www.t3db.ca/biodb/bio_entities/BE0005267,P52435,DNA-directed RNA polymerase II subunit RPB11-a,5439.0,POLR2J,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
79,1407540,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005273,DNA-directed RNA polymerase II subunit RPB11-b1,http://www.t3db.ca/biodb/bio_entities/BE0005273,Q9GZM3,DNA-directed RNA polymerase II subunit RPB11-b1,548644.0,POLR2J3,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
80,1407541,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005272,DNA-directed RNA polymerase II subunit RPB11-b2,http://www.t3db.ca/biodb/bio_entities/BE0005272,Q9H1A7,DNA-directed RNA polymerase II subunit RPB11-b2,,,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
81,1407542,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005424,DNA-directed RNA polymerase II subunit RPB2,http://www.t3db.ca/biodb/bio_entities/BE0005424,P30876,DNA-directed RNA polymerase II subunit RPB2,5431.0,POLR2B,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
82,1407543,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005265,DNA-directed RNA polymerase II subunit RPB3,http://www.t3db.ca/biodb/bio_entities/BE0005265,P19387,DNA-directed RNA polymerase II subunit RPB3,5432.0,POLR2C,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
83,1407658,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0003706,"DNA-directed RNA polymerases I, II, and III subunit RPABC1",http://www.t3db.ca/biodb/bio_entities/BE0003706,P19388,"DNA-directed RNA polymerases I, II, and III subunit RPABC1",5434.0,POLR2E,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
84,1407659,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005269,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",http://www.t3db.ca/biodb/bio_entities/BE0005269,P61218,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",5435.0,POLR2F,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
85,1407660,171349,Toxin and Toxin Target Database (T3DB),Amanullinic acid,T3D3589,Amanullinic acid,http://www.t3db.ca/toxins/T3D3589,BE0005270,"DNA-directed RNA polymerases I, II, and III subunit RPABC3",http://www.t3db.ca/biodb/bio_entities/BE0005270,P52434,"DNA-directed RNA polymerases I, II, and III subunit RPABC3",5437.0,POLR2H,9606,Homo sapiens (human),"The major toxic mechanism of amatoxins is the inhibition of RNA polymerase II, a vital enzyme in the synthesis of messenger RNA (mrna), microrna, and small nuclear RNA (snrna). without mrna, essential protein synthesis, and hence cell metabolism, grind to a halt and the cell dies. (L1774)",,,,,,,
86,1406545,176408,Drug Gene Interaction database (DGIdb),"2-(Furan-2-yl)-7-phenethyl-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine",,AHPN,https://www.dgidb.org/drugs/iuphar.ligand:3431,,MAPK1,https://www.dgidb.org/genes/hgnc:6871,,,5594.0,MAPK1,9606,Homo sapiens (human),,,,,,,,
87,1555141,177880,Comparative Toxicogenomics Database (CTD),"2',3,3',4',5-Pentachlorobiphenyl-4-OL",C111118,"2',3,3',4',5-pentachloro-4-hydroxybiphenyl",https://ctdbase.org/detail.go?type=chem&acc=C111118,1379,CR1L,https://ctdbase.org/detail.go?type=gene&acc=1379,,,1379.0,CR1L,10116,Rattus norvegicus (Norway rat),"2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of CR1L mRNA",,,PMID:19114083,https://www.ncbi.nlm.nih.gov/pubmed/19114083,19114083,,
88,1407417,186002,Comparative Toxicogenomics Database (CTD),"5H-Cyclopenta(b)pyridine-6-carboxylic acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-(2-((2S)-2-carboxypropyl)-4-methoxyphenyl)-6,7-dihydro-, (5S,6R,7R)-",C119319,J 104132,https://ctdbase.org/detail.go?type=chem&acc=C119319,1909,EDNRA,https://ctdbase.org/detail.go?type=gene&acc=1909,,,1909.0,EDNRA,9615,Canis lupus familiaris (dog),J 104132 binds to EDNRA protein,,,PMID:11483691,https://www.ncbi.nlm.nih.gov/pubmed/11483691,11483691,,
89,1407418,186002,Comparative Toxicogenomics Database (CTD),"5H-Cyclopenta(b)pyridine-6-carboxylic acid, 5-(1,3-benzodioxol-5-yl)-2-butyl-7-(2-((2S)-2-carboxypropyl)-4-methoxyphenyl)-6,7-dihydro-, (5S,6R,7R)-",C119319,J 104132,https://ctdbase.org/detail.go?type=chem&acc=C119319,1910,EDNRB,https://ctdbase.org/detail.go?type=gene&acc=1910,,,1910.0,EDNRB,9615,Canis lupus familiaris (dog),J 104132 binds to EDNRB protein,,,PMID:11483691,https://www.ncbi.nlm.nih.gov/pubmed/11483691,11483691,,
90,1407419,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Vanadates inhibits the reaction [aflatoxin B1 results in increased activity of CYP3A4 protein]|aflatoxin B1 results in increased activity of CYP3A4 protein,,,PMID:33164849,https://www.ncbi.nlm.nih.gov/pubmed/33164849,33164849,,
91,1407420,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CYP3A4 mRNA,,,PMID:21641981|PMID:21994236|PMID:29549414|PMID:33984424,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/21994236|https://www.ncbi.nlm.nih.gov/pubmed/29549414|https://www.ncbi.nlm.nih.gov/pubmed/33984424,21641981|21994236|29549414|33984424,,
92,1407421,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),[CYP1A2 protein co-treated with CYP2C9 protein co-treated with CYP3A4 protein co-treated with CYP2D6 protein co-treated with CYP2C19 protein] affects the susceptibility to aflatoxin B1,,,PMID:23397584,https://www.ncbi.nlm.nih.gov/pubmed/23397584,23397584,,
93,1407422,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),CYP3A4 mRNA results in increased susceptibility to aflatoxin B1,,,PMID:29555536,https://www.ncbi.nlm.nih.gov/pubmed/29555536,29555536,,
94,1406988,192705,Therapeutic Target Database (TTD),"Pregnan-20-one, 3-hydroxy-3-(trifluoromethyl)-, (3alpha,5alpha)-",D0AM1S,CCD-3693,https://idrblab.net/ttd/data/drug/details/D0AM1S,T28722,GABA(A) receptor gamma-3 (GABRG3),https://idrblab.net/ttd/data/target/details/T28722,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606,Homo sapiens (human),Modulator,,,,,,,
95,1406989,192706,Drug Gene Interaction database (DGIdb),Phenserine,,PHENSERINE,https://www.dgidb.org/drugs/drugbank:DB04892,,ACHE,https://www.dgidb.org/genes/hgnc:108,,,43.0,ACHE,9606,Homo sapiens (human),,,,,,,,
96,1406990,192711,Drug Gene Interaction database (DGIdb),Cns-5161,,CNS-5161,https://www.dgidb.org/drugs/drugbank:DB05824,,GRIN2A,https://www.dgidb.org/genes/hgnc:4585,,,2903.0,GRIN2A,9606,Homo sapiens (human),,,,,,,,
97,1406991,192711,Drug Gene Interaction database (DGIdb),Cns-5161,,CNS-5161,https://www.dgidb.org/drugs/drugbank:DB05824,,GRIN1,https://www.dgidb.org/genes/hgnc:4584,,,2902.0,GRIN1,9606,Homo sapiens (human),,,,,,,,
98,1406992,192711,Drug Gene Interaction database (DGIdb),Cns-5161,,CNS-5161,https://www.dgidb.org/drugs/drugbank:DB05824,,GRIN2B,https://www.dgidb.org/genes/hgnc:4586,,,2904.0,GRIN2B,9606,Homo sapiens (human),,,,,,,,
99,1406993,193022,Comparative Toxicogenomics Database (CTD),2-Acetamidopent-4-ynoic acid,C092263,N-acetylpropargylglycine,https://ctdbase.org/detail.go?type=chem&acc=C092263,1491,CTH,https://ctdbase.org/detail.go?type=gene&acc=1491,,,1491.0,CTH,9606,Homo sapiens (human),N-acetylpropargylglycine inhibits the reaction [[CTH protein co-treated with cysteine] results in increased chemical synthesis of hydrogen sulfide],,,PMID:18029544,https://www.ncbi.nlm.nih.gov/pubmed/18029544,18029544,,
100,1406994,193962,Drug Gene Interaction database (DGIdb),Etravirine,,ETRAVIRINE,https://www.dgidb.org/drugs/rxcui:475969,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606,Homo sapiens (human),,,,,,,,
101,1406995,194066,Comparative Toxicogenomics Database (CTD),4-Methoxyestrone,C035538,4-hydroxyestrone-4-methyl ether,https://ctdbase.org/detail.go?type=chem&acc=C035538,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,9606,Homo sapiens (human),[[CYP1B1 protein results in increased hydroxylation of estrone] which results in increased chemical synthesis of 4-hydroxyestrone] which results in increased abundance of 4-hydroxyestrone-4-methyl ether,,,PMID:28985473,https://www.ncbi.nlm.nih.gov/pubmed/28985473,28985473,,
102,1406996,195567,Therapeutic Target Database (TTD),2-Formamido-3-[3-[5-(2-formamido-1-hydroxyethyl)-2-hydroxyphenyl]-4-hydroxyphenyl]-3-hydroxypropanoic acid,D09BHF,WF-2421,https://idrblab.net/ttd/data/drug/details/D09BHF,T26623,Aldose reductase (AKR1B1),https://idrblab.net/ttd/data/target/details/T26623,P15121,Aldo-keto reductase family 1 member B1,231.0,AKR1B1,9606,Homo sapiens (human),Modulator,,,,,,,
103,1406997,195821,Therapeutic Target Database (TTD),"N-[1'-[(2R)-6-Cyano-1,2,3,4-tetrahydronaphthalen-2-yl]-4-oxospiro[3H-chromene-2,4'-piperidine]-6-yl]methanesulfonamide;hydrochloride",D00YQZ,L-702958,https://idrblab.net/ttd/data/drug/details/D00YQZ,T20251,Voltage-gated potassium channel Kv11.1 (KCNH2),https://idrblab.net/ttd/data/target/details/T20251,Q12809,Potassium voltage-gated channel subfamily H member 2,3757.0,KCNH2,9606,Homo sapiens (human),Modulator,,,,,,,
